Výsledky vyhledávání - "Mimoza Kotevska Nikolova"

Ml28133 -A Multicenter, Open-Label, Long-Term Extension Study of WA 19926 to Describe Safety During Treatment with Tocilizumab in Patients with Early, Moderate to Severe Rheumatoid Arthritis

Autor: Irena Kafedziska, Anzhelika Stojanovska, Dubravka Antova, Snezhana Mishevska-Perchinkova, Filip Guchev, Mimoza Kotevska Nikolova

Publikováno v: Macedonian Medical Review. 71:83-90

Introduction. Biologic DMARDs (Disease Modifying Anti Rheumatic Drugs) have shown to be effective in the treatment of rheumatoid arthritis (RA) resistant to the use of synthetic DMARDs. The primary goal of this study wasto assess the long-term safety

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4d850ac3d1f3f58bcab70ee58a40f7cd
https://doi.org/10.1515/mmr-2017-0015

Zobrazit plný text záznamu

Multicenter, Open-Label, Long-term Extension to Describe the Safety of Tocilizumab in Patients with Early, Moderate to Severe Rheumatoid Arthritis

Autor: Filip Guchev, Snezhana Mishevska-Perchinkova, Mimoza Kotevska Nikolova, Anzhelika Stojanovska, Irena Kafedziska, Dubravka Antova

Publikováno v: American Journal of Internal Medicine. 8:125

Introduction: Biologic DMARDs (Disease Modifying Anti Rheumatic Drugs) have shown to be effective in the treatment of rheumatoid arthritis (RA) resistant to the use of synthetic DMARDs. The primary goal of this study was to assess the long-term safet

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::492d7430ed71a0d0e079c2701fbf71cb
https://doi.org/10.11648/j.ajim.20200803.16

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání